Skip to main content

Advertisement

Fig. 4 | EJNMMI Research

Fig. 4

From: Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

Fig. 4

Membrane binding and internalisation of 68Ga-PSMA-HBED-CC after 5 h of incubation in androgen-sensitive (revCRPC), castration-resistant prostate cancer cells (CRPC) and abiraterone-insensitive cells (CRPCAA) as well as in revCRPC after 48 h ADT with testosterone (T) withdrawal and 5 μM abiraterone acetate (AA). Values are expressed as percentage of applied radioactivity bound to 106 cells. Mean ± SD (n = 3 cultures)

Back to article page